Life on land and water teeters between haves and have-nots
In the race to make the world more livable for people and nature, progress on land outpaced successes in the seas, raising red flags that wealthier countries’ advantages may be upsetting a balance, a...
Texas A&M research redefines mammalian tree of life
Research led by a team of scientists from the Texas A&M School of Veterinary Medicine and Biomedical Sciences puts to bed the heated scientific debate regarding the history of mammal diversification as it relates...
Twelve outstanding journalists named 2023 MBL Logan Science Journalism Fellows
WOODS HOLE, Mass. –Twelve accomplished science and health journalists have been awarded a highly competitive fellowship in the Logan Science Journalism Program at the Marine Biological Laboratory (MBL).
Credit: Diana Kenney
WOODS HOLE, Mass. –Twelve accomplished...
New approach for efficient engineering of cell and gene therapies
A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, and reduction in cellular toxicity compared to current methods. The approach could also power the development of advanced cell...
Researchers develop novel bio-inspired molecules to enhance bone regeneration
People's ability to regenerate bones declines with age and is further decreased by diseases such as osteoporosis. To help the aging population, researchers are looking for new therapies that improve bone regeneration. Now, an...
Lifespan Extension Record Set In Yeast Cells Using Synthetic Gene Oscillator
A team of University of California San Diego (UCSD) scientists has genetically rewired the circuit that controls cell aging in yeast. From its normal role functioning like a toggle switch, they engineered a negative...
Review article on asymmetric synthesis using arynes
Arynes, synthetic intermediates in which a portion of the benzene ring is a triple bond, have been applied in various organic molecular transformations and have long been of interest to chemists as extremely useful...
Sangamo Eliminating 27% of U.S. Workforce, Refocusing Pipeline
Sangamo CEO Sandy Macrae, PhD
Sangamo Therapeutics will eliminate more than a quarter (27%) of its U.S. workforce—some 120 jobs—and refocus its pipeline on three specialties, as the genomic medicine developer works to bounce back...
Twist and Shout: Helix is Weaving Population Genomics into the Healthcare Fabric
James Lu, MD, PhD, has been interested in the intersection of clinical care and genomics since the early days of next-generation sequencing (NGS) and the dawn of personal genomics in the mid-to-late 2000s.
“In the...
StockWatch: Illumina Wins Back Two Analysts on Q1 Results
Illumina sought to give investors some reasons to be cheerful in the deluge of first-quarter results it released Tuesday after the close of trading.
Yes, Illumina’s quarterly revenue of $1.087 billion was down 11% from...
